Publication | Closed Access

Temocapril, an angiotensin converting enzyme inhibitor, protects against diabetes-induced endothelial dysfunction

Cardiovascular DiseaseDiabetesPhysiologyCardiovascular PharmacologyPharmacologyDiabetes-induced Endothelial DysfunctionEnzyme InhibitorEndothelial DysfunctionVascular BiologyPharmacotherapyMicrovascular DysfunctionMedicineDrug Discovery